Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report.
No Thumbnail Available
Date
2020-05-22
Authors
Pumpure, Elizabete
Dručka, Eva
Kigitoviča, Dana
Meškauskas, Raimundas
Isajevs, Sergejs
Nemiro, Ineta
Rasa, Agnija
Olmane, Evija
Zablocka, Tatjana
Alberts, Pēteris
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.
Description
Keywords
ECHO-7 virus, melanoma, oncology, oncolytic virus, Rigvir, uterine cervix